| Protocol No. | NCI-CIRB-EA8212 |
| Title | NCI-CIRB-EA8212:A Randomized Phase III Trial of Intravesical BCG veRsus Intravesical Docetaxel and GEmcitabine Treatment in BCG Naïve High Grade Non-Muscle Invasive Bladder Cancer (BRIDGE) |
| NCT Number | NCT05538663 (Click to open a new window to clinicaltrials.gov) |
| Principal Investigator | Hensley, Patrick |
| Cancer Types | Urinary Bladder |
| Phase | Phase III |
| Age Group | Adult |
| Drugs Involved | BCG (Bacillus Calmette-Guerin); Bacillus Calmette-Guerin; Gemzar (gemcitabine); Sodium bicarbonate; Taxotere (docetaxel); docetaxel; gemcitabine |
| Status | Open |
| Participating Institutions | Markey Cancer Center; University of Kentucky Medical Center |